HS-234

N/A

Report date: 2024/07/14 20:00:06
NME

Base Information

Drug NameHS-234
Drug Alias NameHS-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonistsEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A